• Apexian Pharmaceuticals, an Indiana - based clinical stage biotechnology company, raised Series A funding of an undisclosed amount. (fortune.com)
• Eureka Therapeutics Inc, an Emeryville, Calif. - based clinical stage biotechnology focused on treating solid tumors, raised $ 60 million in Series D funding. (fortune.com)
«Cancer is like a person's thumbprint; each person's cancer is uniquely theirs,» says Bill Hearl, CEO of Immunomic Therapeutics, a clinical stage biotechnology company developing a nucleic acid immunotherapy platform with the potential to treat cancer, allergies and animal health issues. (scientificamerican.com)